IPSEN BIOPHARMACEUTICALS CANADA INC. is an active federal corporation (corporation number 9066675). Its business number is 827094582. It was incorporated on Oct 29, 2014 under the Canada Business Corporations Act and its registered office is in Mississauga, Ontario. Its annual return for 2026 is due by Dec 28, 2026. It has two directors on record.
Corporate details
- Corporation number
- 9066675
- Business number
- 827094582
- Status
- Active
- Governing law
- Canada Business Corporations Act
- Incorporated
- Oct 29, 2014
- Corporation type
- Non-distributing corporation with 50 or fewer shareholdersAs declared in its 2017 annual return.
- Registered office
- 5050 Satellite Drive
Suite 500
Mississauga ON L4W 0G1 - Number of directors
- At least 1, at most 10As the articles allow.
Annual filings
- Anniversary date
- Oct 29The date of incorporation, amalgamation or continuance.
- Annual filing period
- Oct 29 to Dec 28 each year
- Last annual meeting
- Aug 10, 2017
| Year | Annual return | Annual meeting |
|---|---|---|
| 2026 | Due now Due by Dec 28, 2026 | |
| 2025 | Filed |
The last annual return filed, and each year since.
Directors
Loading the directors from the federal record...
Lobbying the federal government
Registered to lobby the federal government now, and first registered in 2019.
- Registrations
- 1Each consultant hired, and its own in-house registration, is a registration of its own.
- Who lobbies
- Consultants, including 3Sixty Public Affairs Inc.
- Subjects
- Health, Industry, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
- Institutions lobbied
- Global Affairs Canada (GAC), Health Canada (HC), Innovation, Science and Economic Development Canada (ISED), Justice Canada (JC), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Treasury Board Of Canada Secretariat (TBS)
In its latest registration, in its own words
- Innovation, Science and Economic Development Canada regarding the Innovation and Skills Agenda, the Biomanufacturing and Life Sciences Strategy and other government policies and programs related to incentivizing research and development activities in Canada.
- Regulations regarding the exportation of medicines packaged and labelled for the Canadian market to countries other than Canada.
- Patent Act and Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property and approval for therapeutic products.
From the Registry of Lobbyists (Office of the Commissioner of Lobbying), which lists the client as “Ipsen Biopharmaceuticals Canada Inc.”. Shown here because the client's name is this corporation's exact name, and its postal area matches this corporation's registered office. The names of lobbyists and of the officials they met are left out. Contains information licensed under the Open Data Licence Agreement – Office of the Commissioner of Lobbying. Not this company? Tell us.
Names
| Name | Form | In use since |
|---|---|---|
| IPSEN BIOPHARMACEUTICALS CANADA INC. | Name | Oct 29, 2014 |
Filings and certificates
| What | Date |
|---|---|
| Incorporated | Oct 29, 2014 |
Registered in a province as well? Find provincial registrations(opens in a new tab). Something wrong or out of date? Request a correction.